drugset / Trial / NCT02412059

Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear

NCT02412059

RandomizedParallel-groupDouble-blindPrevention

Summary

In this prospective randomized controlled double blind pilot clinical study, we aim to assess whether administration of a topical corticosteroid would attenuate epiretinal membrane formation following development of retinal tears treated with laser retionpexy.

Timeline

Start
2015-08
Primary completion
2016-01
Completion
2016-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 1 % Topical

Indications